Hidrosaluretil

Hidrosaluretil is a prescription oral medication that contains the thiazide diuretic hydrochlorothiazide as its active ingredient. The product is supplied in an oral tablet form, with strength not specified in the available data, and is marketed within the European Union. It belongs to the antihypertensive and diuretic therapeutic classes and is used under medical supervision to manage fluid balance and blood pressure and overall cardiovascular health.

Hidrosaluretil is indicated for several conditions where reduction of excess fluid or control of blood pressure is required.

- Hypertension (high blood pressure) management, often as part of combination therapy. - Edema associated with congestive heart failure, liver cirrhosis, or renal disease. - Fluid retention secondary to chronic kidney disease. - Prevention of calcium‑containing kidney stones in patients with hypercalciuria. - Adjunct therapy in resistant hypertension when other agents are insufficient.

Like other thiazide diuretics, Hidrosaluretil may cause a range of adverse reactions, most of which are mild and reversible.

Common: - Increased urination (polyuria). - Mild electrolyte changes, especially low potassium. - Dizziness or light‑headedness upon standing.

Serious: - Severe electrolyte imbalance causing cardiac arrhythmias. - Acute gout flare due to raised uric acid. - Significant dehydration with hypotension.

Before starting Hidrosaluretil, clinicians should evaluate patient history and monitor specific parameters to minimize risks.

- Assess renal function; avoid use in severe renal impairment. - Monitor serum electrolytes, especially potassium and sodium, during therapy. - Use cautiously in patients with a history of gout or hyperuricemia. - Evaluate blood glucose levels in diabetic patients, as thiazides may raise glucose. - Review concurrent use of other diuretics or antihypertensives to prevent excessive volume loss. - Consider pregnancy status; safety data are limited. - Advise patients to rise slowly from sitting or lying positions to reduce orthostatic dizziness.

Hidrosaluretil can affect the pharmacokinetics or pharmacodynamics of several medicines; awareness of these interactions helps prevent adverse outcomes.

Avoid: - Concurrent use with non‑steroidal anti‑inflammatory drugs (NSAIDs) that may reduce diuretic efficacy. - Combination with other potassium‑depleting agents (e.g., loop diuretics, corticosteroids) that increase risk of hypokalemia. - Co‑administration with lithium, which can raise lithium levels and toxicity.

Use with caution: - ACE inhibitors, ARBs, or beta‑blockers, as additive blood‑pressure lowering may cause hypotension. - Antidiabetic agents, because thiazides may impair glucose control. - Digoxin, due to potential electrolyte‑related sensitization. - Anticoagulants, as volume depletion can affect drug concentration.